Entera Bio Ltd. ENTX and OPKO Health, Inc. OPK recently announced positive topline pharmacokinetic/pharmacodynamic (PK/PD) results from their ongoing collaborative ...
OPK Health, Inc. OPK and Entera Bio Ltd. ENTX recently announced the positive pharmacokinetic outcomes from their joint study that combines Entera's exclusive N-Tab technology with a long-acting, ...
Notably, that recent purchase by Chairman & CEO Phillip Frost was not the only time they bought OPKO Health shares this year. They previously made an even bigger purchase of US$2.3m worth of shares at ...
We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. OPKO Health, Inc. is one of them. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with ...
Hosted on MSN
Opko Health (OPK) Reports Fiscal Q2 2025 Results
Opko Health Inc. (NASDAQ:OPK) is one of the best strong buy penny stocks to buy now. On July 31, Opko Health Inc. (NASDAQ:OPK) reported its fiscal Q2 2025 results, with consolidated total revenues for ...
Opko Health Inc. (NASDAQ:OPK) is one of the best stocks under $5 with highest upside potential. ModeX Therapeutics Inc., an Opko Health Inc. (NASDAQ:OPK) company, announced on October 29 a license and ...
OPKO Health, Inc. ( OPK) announced positive top-line results from the second and final pivotal phase III trial on Rayaldee. OPKO Health is conducting the trial to establish the safety and efficacy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results